Eupraxia Pharmaceuticals growth metrics data for the quarter ended Jun 2026. These growth metrics cover 11 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Jun2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | |||||||||||
| Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) | 38.32% | -30.67% | |||||||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | 123.04% | 11.79% | 58,860.99% | 313.75% | |||||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -2649.00 | 10,616.00 | 7,041.00 | 4,375.00 | 7,471.00 | ||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | -7350.00 | 4,323.00 | 3,149.00 | -2772.00 | 5,915.00 | 749.00 | 483.00 | 324.00 | |||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | 13,282.00 | 8,862.00 | |||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | -4714.00 | 5,235.00 | 815.00 | 512.00 | 359.00 |